All Exams Test series for 1 year @ ₹349 only
Question

A family of a child just diagnosed with acute lymphoblastic leukemia asks about the child's prognosis. Which of the following is a poor prognostic indicator ?

The correct answer is
Presence of mediastinal mass

Prognostic Indicators in Acute Lymphoblastic Leukemia (ALL)

The prognosis of acute lymphoblastic leukemia (ALL) in children depends on several factors. Identifying indicators associated with a poorer outcome is crucial for treatment planning.

Prognostic Factors Analysis

Let's evaluate the given options:

  • Presence of mediastinal mass: This is often associated with T-cell ALL. Mediastinal masses can cause symptoms like respiratory distress and are frequently linked to a higher risk of relapse, making it a poor prognostic indicator.
  • Age between 1 and 10 years: Children diagnosed with ALL between the ages of 1 and 9 years generally have the best prognosis. This is considered a favorable indicator.
  • Hyperploidy with more than 50 chromosomes: In ALL, having a high number of chromosomes (high hyperdiploidy, e.g., >50) is typically associated with a favorable prognosis.
  • WBC count less than 50,000/$mm^3$ at diagnosis: While very high white blood cell (WBC) counts (e.g., >50,000/$mm^3$) are a poor prognostic sign, a count less than 50,000/$mm^3$ is generally considered less concerning and thus leans towards a more favorable prognosis compared to extremely high counts. The most favorable WBC counts are typically much lower (e.g., <10,000/$mm^3$ in infants, <25,000/$mm^3$ in older children).

Poor Prognosis Indicator

Based on the analysis, the presence of a mediastinal mass is the identified poor prognostic indicator among the choices provided.

Was this answer helpful?

Important Questions from Leukemia

  1. The Rai staging system and Binet staging system are the two widely used staging systems used for staging which of the following hematological malignancies?
  2. The BCR-ABL1 oncoprotein exhibits constitutive activity of which one of the following enzymes?
  3. Imatinib, Dasatinib, Nilotinib and Ponatinib are examples of which class of drugs?
  4. Which one of the following is a clonal haematopoietic stem cell disorder in which phenotypically normal red blood cells, granulocytes and platelets accumulate in the absence of a recognizable physiological stimulus?
  5. Which one of the following combinations of drugs can be used for treatment of relapsed myeloma ?
Need Expert Advice?

Start Your Preparation with Prepp Mobile App

Download the app from Google Play & App Store
Download the app from Google Play & App Store
Prepp Mobile App